Digital solutions are needed in healthcare now so that more patients can get the access that they need, according to Vin ...

A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

Participants in the FORWARD-53 trial had clinically significant improvements in time-to-rise, among other metrics.

Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

By 2023, approximately 1 in 5 patients with non-small cell lung cancer or metastatic colorectal cancer were treated with a bevacizumab biosimilar.

The results of a new study in mice show that early exposure to certain bacteria and fungus can give the immune system a boost and reduce the risk of type 1 diabetes.

Marc Humbert, M.D., Ph.D., professor of respiratory medicine at Université Paris-Saclay and Inserm, believes that recent ...

Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...